Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Risk Assessment

View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Oracle Healthcare Acquisition is: No Data: Cannot be evaluated.

Competitive Comparison of Oracle Healthcare Acquisition's Risk Assessment

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oracle Healthcare Acquisition's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's Risk Assessment falls into.

Oracle Healthcare Acquisition (OTCPK:OHAQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Oracle Healthcare Acquisition Risk Assessment Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Executives

Andrew M Weiss	10 percent owner	222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum	10 percent owner	505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc.	10 percent owner	500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc	10 percent owner	51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman	10 percent owner	7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c.	10 percent owner	505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg	director	C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg	director, 10 percent owner	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson	director	12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik	officer: CFO & Secretary
Joel D Liffman	director, officer: President and COO	C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines